China Meheco Group Co., Ltd. (SHSE:600056) agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million on December 19, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.43 CNY | +0.79% | +0.53% | +2.33% |
06:10am | China Meheco Group Chairman, Vice Chairman Resign | MT |
04-29 | China Meheco Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+2.33% | 2.36B | |
+19.14% | 71.7B | |
-3.34% | 23.73B | |
+10.27% | 9.01B | |
+12.67% | 8.72B | |
-17.41% | 8.29B | |
+16.12% | 5B | |
+21.40% | 4.48B | |
-1.41% | 4.08B | |
-2.13% | 3.92B |
- Stock Market
- Equities
- 600056 Stock
- News China Meheco Group Co., Ltd.
- China Meheco Group Co., Ltd. agreed to acquire 46% stake in Hainan General Kangli Pharmaceutical Co., Ltd. from General Technology Group Pharmaceutical Holding, Ltd. for CNY 190 million.